ANAPTYSBIO INC's ticker is ANAB and the CUSIP is 032724106. A total of 132 filers reported holding ANAPTYSBIO INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.2%.
Links
Filings
- All filings
- Annual reports (10-K)
- Quarterly reports (10-Q)
- Insider transactions
- Shareholder votes
- Significant ownership
- Events
EDGAR links
External links
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $32,757,102 | -11.7% | 1,823,892 | -0.0% | 0.00% | 0.0% |
| Q2 2023 | $37,114,502 | -10.0% | 1,824,705 | -3.7% | 0.00% | 0.0% |
| Q1 2023 | $41,245,944 | -28.3% | 1,895,494 | +2.1% | 0.00% | -50.0% |
| Q4 2022 | $57,525,683 | +27.6% | 1,856,266 | +5.0% | 0.00% | 0.0% |
| Q3 2022 | $45,096,000 | +25.2% | 1,767,797 | -0.3% | 0.00% | +100.0% |
| Q2 2022 | $36,009,000 | -20.2% | 1,773,898 | -2.7% | 0.00% | 0.0% |
| Q1 2022 | $45,110,000 | -30.4% | 1,823,395 | -2.2% | 0.00% | -50.0% |
| Q4 2021 | $64,819,000 | +27.7% | 1,865,288 | -0.3% | 0.00% | +100.0% |
| Q3 2021 | $50,746,000 | +5.7% | 1,871,177 | +1.0% | 0.00% | 0.0% |
| Q2 2021 | $48,020,000 | +6.3% | 1,851,904 | -11.7% | 0.00% | 0.0% |
| Q1 2021 | $45,171,000 | +10.1% | 2,096,138 | +9.9% | 0.00% | 0.0% |
| Q4 2020 | $41,017,000 | +44.1% | 1,907,834 | -1.2% | 0.00% | 0.0% |
| Q3 2020 | $28,473,000 | -39.0% | 1,930,420 | -7.5% | 0.00% | -50.0% |
| Q2 2020 | $46,647,000 | +62.6% | 2,088,064 | +2.8% | 0.00% | +100.0% |
| Q1 2020 | $28,694,000 | -13.8% | 2,030,670 | -0.9% | 0.00% | 0.0% |
| Q4 2019 | $33,289,000 | -54.4% | 2,048,614 | -1.9% | 0.00% | -66.7% |
| Q3 2019 | $73,045,000 | -36.9% | 2,087,563 | +1.8% | 0.00% | -40.0% |
| Q2 2019 | $115,681,000 | -12.4% | 2,050,390 | +13.4% | 0.01% | -16.7% |
| Q1 2019 | $132,089,000 | +14.0% | 1,808,203 | -0.5% | 0.01% | 0.0% |
| Q4 2018 | $115,894,000 | -28.6% | 1,816,825 | +11.7% | 0.01% | -14.3% |
| Q3 2018 | $162,341,000 | +56.0% | 1,627,140 | +11.1% | 0.01% | +40.0% |
| Q2 2018 | $104,046,000 | -29.8% | 1,464,624 | +2.9% | 0.01% | -28.6% |
| Q1 2018 | $148,119,000 | +5.5% | 1,423,117 | +2.1% | 0.01% | 0.0% |
| Q4 2017 | $140,334,000 | +488.1% | 1,393,305 | +104.1% | 0.01% | +600.0% |
| Q3 2017 | $23,861,000 | +230.0% | 682,731 | +126.0% | 0.00% | – |
| Q2 2017 | $7,231,000 | +5.0% | 302,156 | +21.7% | 0.00% | – |
| Q1 2017 | $6,888,000 | – | 248,219 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TANG CAPITAL MANAGEMENT LLC | 1,950,609 | $35,032,938 | 4.94% |
| EcoR1 Capital, LLC | 7,521,024 | $135,077,591 | 4.56% |
| Saturn V Capital Management LP | 577,101 | $10,364,734 | 4.34% |
| GREAT POINT PARTNERS LLC | 894,333 | $16,062,221 | 2.93% |
| 5AM Venture Management, LLC | 357,733 | $6,424,885 | 1.85% |
| First Light Asset Management, LLC | 790,806 | $14,202,876 | 1.35% |
| Boxer Capital, LLC | 1,300,000 | $23,348,000 | 1.24% |
| Frazier Life Sciences Management, L.P. | 899,700 | $16,158,612 | 1.07% |
| Deep Track Capital, LP | 1,345,813 | $24,170,801 | 0.93% |
| Palo Alto Investors LP | 431,224 | $7,744,783 | 0.73% |